Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2026-03-21 @ 5:58 PM
Study NCT ID:
NCT00660595
Status:
TERMINATED
Last Update Posted:
2010-09-17
First Post:
2008-04-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-14
First Submit QC Date:
None
Study First Post Date:
2008-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-12-04
Results First Submit QC Date:
None
Results First Post Date:
2010-09-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-08-24
Last Update Post Date:
2010-09-17
Last Update Post Date Type:
ESTIMATED